Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ehrenforth

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|March 7, 1992
Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsS Ehrenforth, W Kreuz, I Scharrer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolismS Ehrenforth, M von Depka Prondsinski, E Aygören-Pürsün, et al.
European Journal of Pediatrics|August 1, 1998
Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophiliaH Vielhaber, S Ehrenforth, H G Koch, et al.
Blood|February 13, 2001
Risk of recurrent venous thrombosis in children with combined prothrombotic risk factorsU Nowak-Göttl, R Junker, W Kreuz, et al.
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691AS Ehrenforth, L Nemes, C Mannhalter, et al.
Blood|February 25, 1999
Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factorsU Nowak-Göttl, C Wermes, R Junker, et al.
Blood|November 9, 2000
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolismM von Depka, U Nowak-Göttl, R Eisert, et al.
Journal of Thrombosis and Haemostasis : JTH|June 17, 2014
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfaS R Lentz, S Ehrenforth, F Abdul Karim, et al.
European Journal of Pediatrics|August 1, 1993
Combined therapy in human immunodeficiency virus-infected children--a 4-year experienceT Güngör, M Funk, R Linde, et al.
Klinische Padiatrie|November 1, 1991
[Hemostatic changes in idiopathic venous thrombosis in childhood and adolescence]U Nowak-Göttl, W D Kreuz, V Hach-Wunderle, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|March 7, 1992
Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsS Ehrenforth, W Kreuz, I Scharrer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolismS Ehrenforth, M von Depka Prondsinski, E Aygören-Pürsün, et al.
European Journal of Pediatrics|August 1, 1998
Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophiliaH Vielhaber, S Ehrenforth, H G Koch, et al.
Blood|February 13, 2001
Risk of recurrent venous thrombosis in children with combined prothrombotic risk factorsU Nowak-Göttl, R Junker, W Kreuz, et al.
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691AS Ehrenforth, L Nemes, C Mannhalter, et al.
Blood|February 25, 1999
Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factorsU Nowak-Göttl, C Wermes, R Junker, et al.
Blood|November 9, 2000
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolismM von Depka, U Nowak-Göttl, R Eisert, et al.
Journal of Thrombosis and Haemostasis : JTH|June 17, 2014
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfaS R Lentz, S Ehrenforth, F Abdul Karim, et al.
European Journal of Pediatrics|August 1, 1993
Combined therapy in human immunodeficiency virus-infected children--a 4-year experienceT Güngör, M Funk, R Linde, et al.
Klinische Padiatrie|November 1, 1991
[Hemostatic changes in idiopathic venous thrombosis in childhood and adolescence]U Nowak-Göttl, W D Kreuz, V Hach-Wunderle, et al.
Pageof 4